Moreover, evidence of cooperation between BRAF activating mutations and PTEN loss in melanoma development was found, suggesting that the activation of MAPK and AKT pathways may be required for melanoma progression (Tsao et al., 2004). The gene discussed is BRAF; the disease is melanoma.